Brind.

Black Diamond Therapeutics, Inc., a US-listed oncology company, announced positive Phase 2b trial results on June 27, 2025, leading to a request for an FDA meeting.

1 report, 0 independent Updated Jun 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

FDA Rupsi Airport

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
Rupsi Airport
airport in India

Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped

Jun 27Unknown outlet